Oncorx Pharmaceuticals

Manufacturing · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Oncorx Pharmaceuticals

Oncorx Pharmaceuticals Inc. is an early-stage pharmaceutical company focused on developing innovative therapies to combat solid tumors and prevent uncontrolled tumor progression. The company specializes in creating small molecule selective β1 integrin antagonists that target therapy-resistant tumor cells, particularly in challenging areas like the brain. Their proprietary drugs are designed to cross the blood-brain barrier effectively, addressing the limitations of current cancer therapies. Oncorx aims to improve patient outcomes by overcoming tumor resistance and enhancing the efficacy of cancer treatments.Explore more
Oncorx Pharmaceuticals's Social MediaPopular SearchesOncorx Pharmaceuticals IncSIC Code 28,283NAICS Code 32,325Show more

Oncorx Pharmaceuticals Org Chart

PhoneEmail
DB
United States flag for contact location.

President & Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Oncorx Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Oncorx Pharmaceuticals

Compare insights from companies similar to Oncorx Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Oncorx Pharmaceuticals

<$5M
1-10
Private
-
2014
DB
Donald BarbeauPresident & Chief Scientific Officer
$13.2M
11-50
Private
-
1998
HB
Hetal BhuvaManager, Digital Marketing
<$5M
11-50
Private
-
-
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
SP
Sarah PaivaQA Specialist III
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
<$5M
2014
Nora Mineva, Co-Founder & Chief Executive Officer, CSO at Adecto Pharmaceuticals
Nora MinevaCo-Founder & CEO, CSO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Oncorx Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Oncorx Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oncorx Pharmaceuticals.

Oncorx Pharmaceuticals Tech Stack

A closer look at the technologies used by Oncorx Pharmaceuticals

Top Manufacturing Companies

Frequently Asked Questions Regarding Oncorx Pharmaceuticals

What is Oncorx Pharmaceuticals's official website?
Oncorx Pharmaceuticals's official website is www.oncorxpharmaceuticals.com
What is Oncorx Pharmaceuticals's Revenue?
Oncorx Pharmaceuticals's revenue is <$5 Million
What is Oncorx Pharmaceuticals's SIC code?
Oncorx Pharmaceuticals's SIC: 28,283
What is Oncorx Pharmaceuticals's NAICS code?
Oncorx Pharmaceuticals's NAICS: 32,325
How many employees does Oncorx Pharmaceuticals have?
Oncorx Pharmaceuticals has 1-10 employees
What industry does Oncorx Pharmaceuticals belong to?
Oncorx Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Oncorx Pharmaceuticals competition?
Oncorx Pharmaceuticals top competitors include: Schwitz Biotech, Turmeric and Curcumin, SaveRxCanada.to, Pharmanest
What technology does Oncorx Pharmaceuticals use?
Some of the popular technologies that Oncorx Pharmaceuticals uses are: GoCentral, Microsoft 365, GoDaddy DNS, GoDaddy SSL Certificates
What does Oncorx Pharmaceuticals do?

Oncorx Pharmaceuticals Inc. is an early-stage pharmaceutical company focused on developing innovative therapies to combat solid tumors and prevent uncontrolled tumor progression. The company specializes in creating small molecule selective β1 integrin antagonists that target therapy-resistant tumor cells, particularly in challenging areas like the... brain. Their proprietary drugs are designed to cross the blood-brain barrier effectively, addressing the limitations of current cancer therapies. Oncorx aims to improve patient outcomes by overcoming tumor resistance and enhancing the efficacy of cancer treatments.Read More

What are Oncorx Pharmaceuticals social media links?
Oncorx Pharmaceuticals Linkedin page
Is Oncorx Pharmaceuticals a public company?
Oncorx Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Oncorx Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.